Carfilzomib (CFZ, Kyprolis (R)), Lenalidomide (LEN, Revlimide (R)), and Dexamethasone (DEX) (KRd) Combined with Autologous Stem Cell Transplant (ASCT) Shows Improved Efficacy Compared with Krd without ASCT in Newly Diagnosed Multiple Myeloma (NDMM)

Zimmerman Todd M.; Griffith Kent; Jasielec Jagoda K.; Rosenbaum Cara A.; Berdeja Jesus G.; Vij Ravi; Raje Noopur; Reece Donna E.; Vesole David H.; Jagannath Sundar; Kaminski Mark; Cole Craig; Nam Jennifer; Stephens Leonor A.; Rosebeck Shaun; Gurbuxani Sandeep; Dytfeld Dominik; Jakubowiak Andrzej J.

首页> 外文期刊>Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation >Carfilzomib (CFZ, Kyprolis (R)), Lenalidomide (LEN, Revlimide (R)), and Dexamethasone (DEX) (KRd) Combined with Autologous Stem Cell Transplant (ASCT) Shows Improved Efficacy Compared with Krd without ASCT in Newly Diagnosed Multiple Myeloma (NDMM)

【24h】

Carfilzomib (CFZ, Kyprolis (R)), Lenalidomide (LEN, Revlimide (R)), and Dexamethasone (DEX) (KRd) Combined with Autologous Stem Cell Transplant (ASCT) Shows Improved Efficacy Compared with Krd without ASCT in Newly Diagnosed Multiple Myeloma (NDMM)

机译：卡非佐米（CFZ，Kyprolis（R）），来那度胺（LEN，Revlimide（R））和地塞米松（DEX）（KRd）结合自体干细胞移植（ASCT）在新诊断的多发性骨髓瘤中的疗效优于未使用ASCT的Krd （NDMM）

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation 》 |2016年第1期| 共1页
作者
Zimmerman Todd M.; Griffith Kent; Jasielec Jagoda K.; Rosenbaum Cara A.; Berdeja Jesus G.; Vij Ravi; Raje Noopur; Reece Donna E.; Vesole David H.; Jagannath Sundar; Kaminski Mark; Cole Craig; Nam Jennifer; Stephens Leonor A.; Rosebeck Shaun; Gurbuxani Sandeep; Dytfeld Dominik; Jakubowiak Andrzej J.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学 ;
关键词

相似文献

外文文献
中文文献

1. Carfilzomib (CFZ, Kyprolis (R)), Lenalidomide (LEN, Revlimide (R)), and Dexamethasone (DEX) (KRd) Combined with Autologous Stem Cell Transplant (ASCT) Shows Improved Efficacy Compared with Krd without ASCT in Newly Diagnosed Multiple Myeloma (NDMM) [J] . Zimmerman Todd M., Griffith Kent, Jasielec Jagoda K., Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2016 ,第3Suppla1期

机译：卡非佐米（CFZ，Kyprolis（R）），来那度胺（LEN，Revlimide（R））和地塞米松（DEX）（KRd）结合自体干细胞移植（ASCT）在新诊断的多发性骨髓瘤中的疗效优于未使用ASCT的Krd （NDMM）
2. Final Results of a Phase 2 Trial of Extended Treatment (tx) with Carfilzomib (CFZ), Lenalidomide (LEN), and Dexamethasone (KRd) Plus Autologous Stem Cell Transplantation (ASCT) in Newly Diagnosed Multiple Myeloma (NDMM) [J] . Zimmerman Todd, Raje Noopur S., Vij Ravi, Blood: The Journal of the American Society of Hematology . 2016 ,第22期

机译：在新诊断的多发性骨髓瘤（NDMM）中加用卡非佐米（CFZ），来那度胺（LEN）和地塞米松（KRd）加上自体干细胞移植（ASCT）的扩展治疗（tx）的2期试验的最终结果
3. Frontline Therapy with Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Induction Followed By Autologous Stem Cell Transplantation, Krd Consolidation and Lenalidomide Maintenance in Newly Diagnosed Multiple Myeloma (NDMM) Patients: Primary Results of the Intergroupe Francophone Du MyeLome (IFM) Krd Phase II Study [J] . Roussel Murielle, Lauwers-Cances Valerie, Robillard Nelly, Blood: The Journal of the American Society of Hematology . 2016 ,第22期

机译：卡非佐米，来那度胺和地塞米松（KRd）诱导的一线治疗，然后是新诊断的多发性骨髓瘤（NDMM）患者的自体干细胞移植，Krd合并和来那度胺维持：组间法语国语双歧双歧（IFM）Krd II期研究的主要结果
4. Consolidation with carfilzomib lenalidomide and dexamethasone (KRd) following ASCT results in high rates of minimal residual disease negativity and improves bone metabolism in the absence of bisphosphonates among newly diagnosed patients with multiple myeloma [O] . Maria Gavriatopoulou, Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, 2020

机译：在新诊断的多发性骨髓瘤患者中在接受ASCT后与卡非佐米来那度胺和地塞米松（KRd）合并可导致较高的最小残留疾病阴性率并改善骨骼代谢而无需使用双膦酸盐。
5. Carfilzomib (CFZ, Kyprolis®), Lenalidomide (LEN, Revlimid®), and Dexamethasone (DEX) (KRd) Combined with Autologous Stem Cell Transplant (ASCT) Shows Improved Efficacy Compared with Krd without ASCT in Newly Diagnosed Multiple Myeloma (NDMM) [O] . Todd M. Zimmerman, Kent Griffith, Jagoda K. Jasielec, 2016

机译：Carfilzomib（CFZ，Kyprois®），Lenalidomide（Len，RevlimID®）和地塞米松（DEX）（DEX）（DEX）与自体干细胞移植（ASCT）相结合，与KRD相比，在新诊断出的多发性骨髓瘤（NDMM）中没有krd的效果

Carfilzomib (CFZ, Kyprolis (R)), Lenalidomide (LEN, Revlimide (R)), and Dexamethasone (DEX) (KRd) Combined with Autologous Stem Cell Transplant (ASCT) Shows Improved Efficacy Compared with Krd without ASCT in Newly Diagnosed Multiple Myeloma (NDMM)

著录项

相似文献

相关主题

期刊订阅